In a recent post on the IVI-sponsored Health Affairs featured blog series, Jonathan Darrow, Aaron Kesselheim, and Jessica Lasky-Su outline the goals and promise of the Precision Medicine Initiative and Cancer Moonshot. Although they also outline some of the key challenges and limitations, the authors recognize that there is a significant opportunity to translate the advances to be made through these precision medicine initiatives into meaningful improvements in clinical care.
Read the full article here.
About the Health Affairs/IVI Featured Blog Series: Drugs and Medical Innovation — In partnership with Health Affairs, IVI is proud to sponsor the “Drugs and Medical Innovation” blog series. On an ongoing basis, articles in this series will explore topics such as value-based reimbursement, drug policy and pricing, balancing short-term access against long-term rates of innovation, and other relevant issues. Our goal is to create an open forum for sharing ideas and debating issues in these areas, extending the discussion to a broader audience.
